The goal of the study is to understand and learn from The TMA member community about their experiences with receiving vaccinations before and after a rare neuroimmune disorder diagnosis, with a focus on their experiences after diagnosis. The study involves participation in a survey administered using Surveymonkey and through postal mail.
This study is being conducted in two parts. The first part is a random sample of 600 members of the TMA. Once the random sample has been recruited, we will open enrollment to all members of the TMA.